Spina bifida and pediatric cancers.
Birth defects
central nervous system tumors
childhood cancer epidemiology
folate
spina bifida
Journal
Pediatric hematology and oncology
ISSN: 1521-0669
Titre abrégé: Pediatr Hematol Oncol
Pays: England
ID NLM: 8700164
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
pubmed:
5
5
2020
medline:
27
1
2021
entrez:
5
5
2020
Statut:
ppublish
Résumé
Spina bifida has been reported to co-occur with pediatric cancer, but comprehensive evaluations remained elusive. We investigated this co-occurrence in two large, population-based studies in Taiwan (N = 1900 cancer cases, 2,077,137 controls) and Denmark (N = 5508 cases, 137,700 controls). Analyses in Denmark were restricted to the period before prenatal diagnostics became available (2004) and pregnancy terminations of fetuses with birth defects became more common. Using national patient and cancer registries, we linked spina bifida and cancer diagnoses among cases and non-cases. The risk of spina bifida among all cancer cases was increased and similar in Denmark [odds ratio (OR)=8.4, 95% confidence interval (CI) 5.1-13.8] and Taiwan (OR = 8.5, 95% CI 4.0-17.8), particularly for central nervous system (CNS) tumors (Denmark: OR = 16.3, 95% CI 8.1-33.0; Taiwan: OR = 26.6, 95% CI 8.5, 83.1), including benign CNS tumors (Denmark: OR = 41.5, 95% CI 21.2, 81.4). These findings suggest the need for comprehensive investigation of shared risk factors in the link between spina bifida and pediatric cancer.
Identifiants
pubmed: 32364426
doi: 10.1080/08880018.2020.1760409
pmc: PMC7577564
mid: NIHMS1637317
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
630-636Subventions
Organisme : NIEHS NIH HHS
ID : R03 ES021643
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA175959
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001881
Pays : United States
Références
PLoS One. 2013 Sep 20;8(9):e75428
pubmed: 24147155
Pediatr Blood Cancer. 2019 Jan;66(1):e27461
pubmed: 30255546
Pediatr Hematol Oncol. 2003 Apr-May;20(3):261-4
pubmed: 12637224
Am J Hum Genet. 1997 Mar;60(3):474-85
pubmed: 9042906
Am J Med Genet A. 2014 Sep;164A(9):2250-5
pubmed: 24934283
Cancer Epidemiol. 2017 Aug;49:202-215
pubmed: 28715709
J Neurosurg. 1998 Nov;89(5):844-51
pubmed: 9817426
Neurotoxicology. 2017 Jul;61:20-31
pubmed: 27000518
J Pediatr. 2012 Jun;160(6):978-83
pubmed: 22244463
JAMA Oncol. 2019 Jun 20;:
pubmed: 31219523
Neuro Oncol. 2013 Nov;15 Suppl 2:ii1-56
pubmed: 24137015
J Pediatr. 1998 Nov;133(5):617-23
pubmed: 9821417
Birth Defects Res. 2019 Feb 1;111(3):151-158
pubmed: 30561844
Acta Oncol. 1991;30(5):579-81
pubmed: 1892674
Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2716-36
pubmed: 25192704
Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):1933-41
pubmed: 22941336
Acta Oncol. 2009;48(5):791-800
pubmed: 19225948
Biomed Res Int. 2018 Feb 1;2018:9203985
pubmed: 29487873
Eur J Pediatr. 1990 May;149(8):594-5
pubmed: 2161343
Am J Public Health. 2016 Jan;106(1):e24-34
pubmed: 26562127
Int J Cancer. 2020 Sep 1;147(5):1343-1353
pubmed: 32020595
PLoS One. 2017 Jul 27;12(7):e0181246
pubmed: 28749971
PLoS One. 2013 Jul 17;8(7):e69077
pubmed: 23874873